8-K/A

AMENDMENT TO FORM 8-K

Company: Eloxx Pharmaceuticals, Inc.
Filed: November 15, 2006
Period of Report: November 8, 2006
Accession Number: 0001104659-06-075449

View Document ↗ View on SEC.gov ↗